Riskpilot← Back to searchSign inGet full accessCOLOPLAST NORGE AS
ASActiveOrg 931925822Ryenstubben 10, 0679 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 198146 employeeswww.coloplast.no
Revenue 2024
NOK 449,6M
+4% vs 2023
EBITDA margin
7.5%
-16% vs 2023
Equity ratio
13.7%
Financial strength
Net profit 2024
NOK 27,2M
-14% vs 2023
| Revenue | NOK 449,6M | +4% |
| EBITDA | NOK 33,9M | -16% |
| Net profit | NOK 27,2M | -14% |
| Total assets | NOK 95,8M | +8% |
| Equity | NOK 13,1M | +8% |
| Employees | 46 | — |
Legal name
COLOPLAST NORGE AS
Org number
931925822
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17. september 1981
Share capital
—
Employees
46 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Address
Ryenstubben 10, 0679 Oslo
Phone
+4722575000
Email
post@coloplast.no
Website
www.coloplast.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 386 533 | 395 380 | 415 099 | 433 398 | 449 647 |
| Staff expenses | −31 970 | −33 029 | −36 692 | −38 280 | −44 032 |
| EBITDA | 29 862 | 30 892 | 35 167 | 40 500 | 33 885 |
| Depreciation & amort. | −337 | −313 | −323 | −471 | −758 |
| EBIT | 29 525 | 30 579 | 34 845 | 40 029 | 33 126 |
| Net financials | 1 669 | 1 377 | −397 | 946 | 1 950 |
| Profit before tax | 31 195 | 31 956 | 34 448 | 40 975 | 35 076 |
| Tax | 6 959 | 7 132 | 7 734 | 9 134 | 7 836 |
| Net profit | 24 235 | 24 825 | 26 714 | 31 841 | 27 240 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 87 986 | 108 242 | 91 832 | 89 039 | 95 767 |
| Equity | 11 281 | 14 242 | 6 256 | 12 105 | 13 086 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 76 705 | 94 000 | 85 576 | 76 934 | 82 681 |
| Total debt | 76 705 | 94 000 | 85 576 | 76 934 | 82 681 |
EBITDA margin
7.5%
This company
15.8%
Market median
-53% vs market
20202024
Equity ratio
13.7%
This company
38.2%
Market median
-64% vs market
20202024
Return on equity
208.2%
This company
18.4%
Market median
+1032% vs market
20202024
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
20202024
Asset turnover
4.70×
This company
1.12×
Market median
+320% vs market
20202024
Debt / equity
6.32×
This company
0.62×
Market median
-919% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-10-01 – 2020-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LN Chief Executive Officer | Chief Executive Officer | 2026 |
RM Chief Executive Officer | Chief Executive Officer | 2001 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Coloplast Danmark As | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of COLOPLAST NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Nymo Helli | Chief Executive Officer | 0 companies |
| Reidar Mathisen | Chief Executive Officer | 0 companies |
| Henning Reichardt | Chairman | 0 companies |
| Claus Lundbæk Ottosen | Board of Directors | 0 companies |
| Henrik Deneke | Board of Directors | 0 companies |
| Anton Malling Mikkelsen | Board of Directors | 0 companies |
| Hea Vinskov | Board of Directors | 0 companies |